Dobutamine description: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Dobutamine}} {{CMG}}; {{AE}} {{AZ}} ==Description== Dobutamine Injection, USP is 1,2-benzenediol, 4-[2-[[3-(4-hydro-xyphenyl)-1-methylpropyl]amino]ethyl]-hydroch...")
 
(Redirected page to Dobutamine#Structure)
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Dobutamine#Structure]]
{{Dobutamine}}
{{CMG}}; {{AE}} {{AZ}}


==Description==
[[Category: Cardiovascular Drugs]]
 
[[Category: Drug]]
Dobutamine Injection, USP is 1,2-benzenediol, 4-[2-[[3-(4-hydro-xyphenyl)-1-methylpropyl]amino]ethyl]-hydrochloride, (±). It is a synthetic catecholamine.
 
{|
|fig
|}
 
The clinical formulation is supplied in a sterile form for intravenous use only. Each mL contains: Dobutamine hydrochloride, equivalent to 12.5 mg (41.5 µmol) dobutamine; 0.24 mg sodium metabisulfite (added during manufacture), and water for injection. pH adjusted between 2.5 to 5.5 with hydrochloric acid and/or sodium hydroxide. Dobutamine is oxygen sensitive.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = DOBUTAMINE (DOBUTAMINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cb842dc2-fb15-48f9-e4b1-ea4280db0199 | publisher =  | date =  | accessdate =  }}</ref>
 
==References==
{{Reflist}}
 
{{FDA}}
 
[[Category:Drugs]]

Revision as of 20:06, 21 July 2014